Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
By Svea Herbst-Bayliss
NEW YORK (Reuters) – Activist investor Ananym Capital Administration plans to appoint as many as half a dozen administrators to the board at Henry Schein (NASDAQ:HSIC), arguing the dental and medical distributor wants to begin looking for a brand new CEO, minimize prices and optimize capital allocation, three sources aware of the matter stated.
The hedge fund, launched in September by veteran traders Charlie Penner and Alex Silver, might announce its slate inside the subsequent weeks, selecting executives skilled in healthcare distribution and enterprise transformation, the sources stated.
Henry Schein, valued at $9.3 billion, has 13 board members, together with Chairman and Chief Government Stanley Bergman, 75, who has served as a director for greater than 4 many years. 5 administrators have been on the board for a dozen years or extra.
A full-blown board problem would dial up the stress on Henry Schein after the corporate and hedge fund held casual talks late final yr. Ananym stays involved that extra substantive discussions haven’t taken place.
A consultant for Henry Schein didn’t instantly reply to a request for remark.
The corporate has beforehand stated that it repeatedly engages in dialogue with traders to reinforce shareholder worth and analyzes their enter in that context.
The proxy combat could be among the many first of the brand new yr. Bankers and attorneys say extra firms might face pricey battles with shareholders in 2025 over sizzling button points starting from CEO succession to placing themselves up on the market.
Nevertheless, Ananym might additionally again off from a board problem, topic to some kind of settlement or additional bulletins from Henry Schein, the sources stated.
Penner and Silver have argued that Henry Schein wants recent blood on the board to instantly contemplate succession planning for Bergman. Ananym owns 471,000 shares in Henry Schein and the place is the largest for the fund, which oversees $250 million.
Traders fret that little planning has been dedicated to what occurs after Bergman leaves.
A number of Henry Schein senior executives exited after only some years on the job, together with Jonathan Koch, former CEO of Henry Schein’s International Dental Group, and A.J. Caffentzis, former president of its U.S. dental division.
The departures raised issues that high executives who might need been potential CEO candidates see no future for themselves on the firm.
The hedge fund additionally argued that spending has spiraled uncontrolled and that Henry Schein wants to higher combine acquisitions, the folks stated.
Henry Schein must also reallocate capital spending towards repurchasing its undervalued inventory and away from mergers and acquisitions till prior offers are built-in, Ananym has stated.
The inventory worth has climbed roughly 10% since Ananym’s involvement was first reported in November by Reuters. It closed at $74.78 on Wednesday, after buying and selling largely flat over the past 52 weeks.
Traders have expressed concern that Henry Schein is complacent and happy to outperform solely its direct dental distribution friends Patterson and Benco, as a substitute of benchmarking its operational effectivity towards the most important U.S. healthcare distribution firms like Cardinal Well being (NYSE:CAH), Cencora, and McKesson (NYSE:MCK).
Penner, a former companion at activist Jana Companions, efficiently challenged Exxon Mobil (NYSE:XOM)’s board in 2021 at upstart investor Engine No. 1. Silver was a founding companion at P2 Capital Companions (WA:CPAP).
